MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Senior Product Manager, Patient Marketing for LIVMARLI, will play a critical support role to the Senior Marketing Director in the strategic and tactical execution of marketing initiatives to support the continued success of LIVMARLI. This individual will help plan, coordinate, and implement key brand activities across digital, field, patient, and healthcare provider channels.
This role is ideal for a motivated, resourceful, and digitally-savvy professional who is eager to learn, take ownership of meaningful projects, and grow within a high-performing, mission-driven commercial team.
JOB FUNCTIONS/RESPONSIBILITIES
Brand & Marketing Support
- Partner with the Senior Director, Marketing to execute the annual brand plans for LIVMARLI.
- Assist in developing marketing materials (Patient/caregiver, digital, etc.) in alignment with strategic objectives and compliance standards.
- Support execution of omnichannel marketing initiatives, including HCP and patient campaigns, digital content, CRM/email marketing, and social media.
- Coordinate review and approval (MLR) processes, ensuring materials are accurate, timely, and compliant.
- Support tactical execution of field force tools and branded and unbranded education initiatives.
- Manage creative and digital agency partners, ensuring deliverables are high-quality, compliant, and on-time.
- Support ongoing field team enablement through tools, resources, and internal communications.
- Maintain awareness of emerging digital tools and rare disease engagement innovations.
- Help maintain brand budgets and timelines.
- Prepare summaries, presentations, and reports for leadership and brand review meetings.
- Work closely with cross-functional partners (Medical Affairs, Market Access, Patient Services, Commercial Operations, and Field Teams) to ensure alignment and seamless execution.
Qualifications
Education & Experience
- Bachelor’s degree in business, marketing, life sciences, or related field required
- 3–6 years of experience in pharmaceutical marketing, product management, or commercial operations, ideally in rare disease.
Knowledge, Skills and Abilities:
- Strong organizational, project management, and communication skills.
- High attention to detail with ability to manage multiple priorities and deadlines.
- Digital fluency – comfortable with CRM systems, analytics platforms, and digital campaign tools.
- Analytical mindset – able to synthesize data and insights to inform decisions.
The salary range for this position is $175,000 to $185,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.
#LI-HYBRID
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Skills Required
- Bachelor's degree in business, marketing, life sciences, or related field
- 3-6 years of experience in pharmaceutical marketing, product management, or commercial operations
- Strong organizational, project management, and communication skills
- High attention to detail with ability to manage multiple priorities and deadlines
- Digital fluency - comfortable with CRM systems, analytics platforms, and digital campaign tools
- Analytical mindset - able to synthesize data and insights to inform decisions
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
.png)
